SCHEMBL7913181

SCHEMBL7913181

CN(C)CC#CCOC(=O)C(O)c1ccccc1C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 4/20 0.43
CYP3A4 P08684 3/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 3/20 0.43
KCNH2 Q12809 3/20 0.43
CHRM1 P11229 3/20 0.43
SLC6A2 P23975 3/20 0.43
ADRA1A P35348 3/20 0.43
OPRM1 P35372 3/20 0.43
DRD3 P35462 3/20 0.43
CYP2C19 P33261 2/20 0.43
CHRM2 P08172 2/20 0.43
SLC6A3 Q01959 2/20 0.43
CYP2C9 P11712 2/20 0.43
TBXA2R P21731 2/20 0.43
PKM P14618 1/20 0.43
NFKB1 P19838 1/20 0.43
THPO P40225 1/20 0.43
ABCB11 O95342 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8578195 0.93 CYP3A4 (0.43) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL3365274 0.91 CHRM2 (0.53) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL7914136 0.86 PTGDR2 (0.40) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL8524436 0.85 CHRM2 (0.46) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL3364418 0.84 PTGDR2 (0.38) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL8475476 0.83 PTGDR2 (0.36) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL8473282 0.81 PTGDR2 (0.35) ADRA2ACYP3A4CYP1A2CYP2D6KCNH2
SCHEMBL290175 0.80 TSHR (0.45) ADRA2ACYP1A2CYP2D6KCNH2CHRM1
SCHEMBL25188997 0.78 SLC6A2 (0.43) ADRA2ACYP1A2CYP2D6KCNH2CHRM1
SCHEMBL11467456 0.77 PTGDR2 (0.43) SLC6A2SLC6A3MEN1KMT2APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207852-B1 THERAPY FOR INCONTINENCE; CROHN'S DISEASE; MUSCLE RELAXANTS BRIDGE PHARMA, INC. 2001-03-27 US disclosed